Factors associated with PTLFU after diagnosis among people with drug-susceptible TB (Gap 3). by Tulip A. Jhaveri (18625800)

“…Only statistically significant findings are presented. Some studies with adjusted analyses reported nonsignificant associations for sex [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref040" target="_blank">40</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref056" target="_blank">56</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref057" target="_blank">57</a>], age [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref040" target="_blank">40</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref055" target="_blank">55</a>], educational attainment [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref055" target="_blank">55</a>], and previous TB treatment [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref055" target="_blank">55</a>]. …”

Factors associated with mortality after TB treatment (without evaluation of TB recurrence) (Gap 5). by Tulip A. Jhaveri (18625800)

“…Effect estimates greater than 1 represent increased mortality risk; estimates less than 1 represent decreased mortality risk. Study labels indicate: [a] effect estimates are hazard ratios; [b] effect estimates are odds ratios; [c] effect estimates are incidence rate ratios; [d] posttreatment mortality was reported as a single outcome; [e] posttreatment mortality was reported as part of a composite outcome including on-treatment mortality; and [f] unhealthy or severe alcohol use was defined as AUDIT-C score > = 4. …”

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... by P.G.J. ter Horst (21743830)

Subjects:

The pathway of significant lung cancer-associated proteins enrichment. by Zhangyan Lyu (4070221)

Subjects:

Forest plot of the significant lung cancer-associated proteins. by Zhangyan Lyu (4070221)

Subjects:

Forest plot of evidence grading for significant associations with the risk of prostate cancer in categories from meta-analyses. by Huijie Cui (5580227)

Subjects:

Causal inference results: MR results for biomarkers significantly associated with eGFR in cross-sectional analyses. by Amena Keshawarz (11528926)

Subjects:

Venn diagram of number of genes found significantly associated with MCP in MAGMA gene-based test analyses. by Keira J. A. Johnston (6836690)

Funnel plot demonstrating lack of publication bias across all studies that met our review’s inclusion criteria. by Jessica Craig (409538)

Subjects:

Subgroup analyses of the aortic lesion area. by SiJin Li (12488187)

Meta-analyses were performed to aggregate the HRs for continuous (A) and binary (B) GSRS after excluding the GSE167573 cohort. by Yu Zhang (12946)

Subjects:

Anaesthesia decreases stimulus-specific suppression on probe-responses only after communication context. by Luciana López-Jury (8601540)

Sensitivity analyses. by Heping Xu (95297)

Subjects:

Nasal microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Gut microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Imputed HLA alleles and its correlation with variant of interest—rs9274619:A. by Margaret Sunitha Selvaraj (13994016)

Subjects:

association analyses by Zhao Wensha (20747495)

Association of significant proteins with lung cancer in UK Biobank Cohort. by Zhangyan Lyu (4070221)

Subjects:

Table1_Gene-wide significant association analyses of DNMT1 genetic variants with Parkinson’s disease.DOCX by Jian-Yong Wang (495372)

“…Four representing tag-SNPs (rs16999593, rs2162560, rs11880553, and rs9305012) were identified and genotyped in a Han Chinese population comprising 712 PD patients and 696 controls. Association analyses were performed at gene-wide significance (p < 1.8 × 10⁻³).…”

Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. by Courtney A. Swain (15170264)